Ageing, ACE2 deficiency and bad outcome in COVID-19
- PMID: 34118797
- DOI: 10.1515/cclm-2021-0658
Ageing, ACE2 deficiency and bad outcome in COVID-19
Comment on
-
Role of ACE2 polymorphism in COVID-19: impact of age.Clin Chem Lab Med. 2021 May 13. doi: 10.1515/cclm-2020-1877. Online ahead of print. Clin Chem Lab Med. 2021. PMID: 33984877
References
-
- Centers for Disease Control and Prevention. Science Brief: evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/underly... [Accessed 30 May 2021].
-
- Wu, Z, McGoogan, JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42. https://doi.org/10.1001/jama.2020.2648.
-
- Mohaghegh, S, Motie, P, Motamedian, SR, Beheshti, S. Role of ACE2 polymorphism in Covid-19: impact of age. Clin Chem Lab Med 2021; https://doi.org/10.1515/cclm-2020-1877 59;1623–7.
-
- Goldstein, E, Lipsitch, M, Cevik, M. On the effect of age on the transmission of SARS-CoV-2 in households, schools, and the community. J Infect Dis 2021;223:362–9. https://doi.org/10.1093/infdis/jiaa691.
-
- Wambier, CG, Goren, A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol 2020;83:308–9. https://doi.org/10.1016/j.jaad.2020.04.032.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials